China Journal of Leprosy and Skin Diseases ›› 2025, Vol. 41 ›› Issue (3): 202-203.doi: 10.12144/zgmfskin202503202

• Case Reports • Previous Articles     Next Articles

Successful treatment of eosinophilic pustular folliculitis with dupilumab: a case report

SUN Yanhong1,2, ZHAO Qing1,2, ZHOU Jun3, ZHANG Furen1,2   

  1. 1 Hospital for Skin Diseases, Shandong First Medical University, Jinan 250022, China; 2 Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan 250022, China; 3 Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China
  • Online:2025-03-15 Published:2025-03-03

Abstract: This is the first report in China on the successful treatment of eosinophilic pustular folliculitis with dupilumab, and only one case has been reported abroad. A 33-year-old man presented with eruption on the trunk for 8 years, and similar lesions with exudation on the face for 2 months. According to the laboratory examination and pathological examination, the diagnosis of eosinophilic pustular folliculitis was made. Dupilumab was given to the patient because of poor response to a variety of oral and topical drugs. After 3 days of dupilumab treatment, the skin lesions began to improve gradually, and eight weeks later, the skin lesions on the face, chest and back basically subsided, with pigmentation remaining.

Key words: eosinophilic pustular folliculitis, dupilumab